Pharnext (XPAR:ALPHA) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Pharnext Days Sales Outstanding?

Pharnext's average Accounts Receivable for the six months ended in Dec. 2023 was €0.05 Mil. Pharnext's Revenue for the six months ended in Dec. 2023 was €-0.14 Mil.

The historical rank and industry rank for Pharnext's Days Sales Outstanding or its related term are showing as below:

XPAR:ALPHA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 1551.25 Med: 1583.84 Max: 1616.43
Current: 1551.25

During the past 12 years, Pharnext's highest Days Sales Outstanding was 1616.43. The lowest was 1551.25. And the median was 1583.84.

XPAR:ALPHA's Days Sales Outstanding is ranked worse than
96.75% of 893 companies
in the Biotechnology industry
Industry Median: 73.34 vs XPAR:ALPHA: 1551.25

Pharnext's Days Sales Outstanding declined from Dec. 2022 (808.21) to Dec. 2023 (0.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Pharnext Days Sales Outstanding Historical Data

The historical data trend for Pharnext's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharnext Days Sales Outstanding Chart

Pharnext Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

1,616.43

1,551.25

Pharnext Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	808.21	37.72	-

Competitive Comparison of Pharnext's Days Sales Outstanding

For the Biotechnology subindustry, Pharnext's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharnext's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharnext's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Pharnext's Days Sales Outstanding falls into.

Pharnext Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Pharnext's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.031	+	0.054)	/	2 )	/	0.01	*	365
=	0.0425					/	0.01	*	365
=	1,551.25

Pharnext's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0.054)	/	1 )	/	-0.14	*	365 / 2
=	0.054					/	-0.14	*	365 / 2
=	N/A

Pharnext (XPAR:ALPHA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Pharnext Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Pharnext's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharnext (XPAR:ALPHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharnext SA (XPAR:ALPHA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

P0X0:Germany

Address

11-13 Rue Rene Jacques, Issy-Les-Moulineaux, FRA, 92130

Website

http://www.pharnext.com

Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.

Pharnext (XPAR:ALPHA) Headlines

No Headlines